HRS9432

HRS9432 · Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS9432, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis [Phase 2]